File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Endoluminal stent grafts for aortic diseases: Experience at a major teaching hospital in Hong Kong

TitleEndoluminal stent grafts for aortic diseases: Experience at a major teaching hospital in Hong Kong
Authors
KeywordsAortic disease
Endoluminal stent grafts
Issue Date2003
PublisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/ANS
Citation
Anz Journal Of Surgery, 2003, v. 73 n. 3, p. 100-104 How to Cite?
AbstractBackground: The purpose of the present paper was to review the initial experience of an endovascular aortic stent graft program at a major teaching hospital in Hong Kong. Methods: Demographics, operative details, complications and follow-up data of all the patients receiving endovascular repair for aortic disease were recorded prospectively. Results: Between July 1999 and December 2001, endovascular repairs were attempted in 39 patients with aortic disease. The procedural success rate was 97.4%. Thirty-three procedures were for abdominal aorto-iliac aneurysms. Graft configuration was bifurcated in 28 patients (85%) while an aorto-uni-iliac device with a femoro-femoral bypass was carried out in the remaining five patients. Thoracic procedures were carried out for one thoracic aortic aneurysm, two traumatic thoracic aortic injuries, one thoracic aortic dissection, and one thoracic aortic pseudoaneurysm with aorto-oesophageal fistula. There was one hospital mortality (2.6%) from a type A thoracic aortic dissection with cardiac tamponade. Postoperative complications were seen in seven patients (18%). With a mean follow-up of 11.6 ± 8.1 months, there was no open conversion or rupture. The endoleak rate was 27% at discharge, 15% at 6 months and 5% at 12 months postoperatively. For aneurysm endografts, the aneurysm sac decreased in size in 21 patients (62%), and remained static in 13 patients (38%). Conclusions: The endoluminal stent graft appears to be a promising device that can be used safely in selected patients with aortic disease. Continued follow-up is required to monitor the presence of endoleak and the size of the aneurysm sac.
Persistent Identifierhttp://hdl.handle.net/10722/83923
ISSN
2015 Impact Factor: 1.158
2015 SCImago Journal Rankings: 0.432
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorTing, ACWen_HK
dc.contributor.authorCheng, SWKen_HK
dc.contributor.authorHo, Pen_HK
dc.date.accessioned2010-09-06T08:46:49Z-
dc.date.available2010-09-06T08:46:49Z-
dc.date.issued2003en_HK
dc.identifier.citationAnz Journal Of Surgery, 2003, v. 73 n. 3, p. 100-104en_HK
dc.identifier.issn1445-1433en_HK
dc.identifier.urihttp://hdl.handle.net/10722/83923-
dc.description.abstractBackground: The purpose of the present paper was to review the initial experience of an endovascular aortic stent graft program at a major teaching hospital in Hong Kong. Methods: Demographics, operative details, complications and follow-up data of all the patients receiving endovascular repair for aortic disease were recorded prospectively. Results: Between July 1999 and December 2001, endovascular repairs were attempted in 39 patients with aortic disease. The procedural success rate was 97.4%. Thirty-three procedures were for abdominal aorto-iliac aneurysms. Graft configuration was bifurcated in 28 patients (85%) while an aorto-uni-iliac device with a femoro-femoral bypass was carried out in the remaining five patients. Thoracic procedures were carried out for one thoracic aortic aneurysm, two traumatic thoracic aortic injuries, one thoracic aortic dissection, and one thoracic aortic pseudoaneurysm with aorto-oesophageal fistula. There was one hospital mortality (2.6%) from a type A thoracic aortic dissection with cardiac tamponade. Postoperative complications were seen in seven patients (18%). With a mean follow-up of 11.6 ± 8.1 months, there was no open conversion or rupture. The endoleak rate was 27% at discharge, 15% at 6 months and 5% at 12 months postoperatively. For aneurysm endografts, the aneurysm sac decreased in size in 21 patients (62%), and remained static in 13 patients (38%). Conclusions: The endoluminal stent graft appears to be a promising device that can be used safely in selected patients with aortic disease. Continued follow-up is required to monitor the presence of endoleak and the size of the aneurysm sac.en_HK
dc.languageengen_HK
dc.publisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/ANSen_HK
dc.relation.ispartofANZ Journal of Surgeryen_HK
dc.subjectAortic diseaseen_HK
dc.subjectEndoluminal stent graftsen_HK
dc.titleEndoluminal stent grafts for aortic diseases: Experience at a major teaching hospital in Hong Kongen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0004-8682&volume=73&spage=100&epage=104&date=2003&atitle=Endoluminal+stent+grafts+for+aortic+diseases+-+experience+at+a+major+teaching+hospital+in+Hong+Kongen_HK
dc.identifier.emailCheng, SWK: wkcheng@hkucc.hku.hken_HK
dc.identifier.authorityCheng, SWK=rp00374en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1046/j.1445-2197.2003.02655.xen_HK
dc.identifier.pmid12608967-
dc.identifier.scopuseid_2-s2.0-0037366466en_HK
dc.identifier.hkuros82480en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0037366466&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume73en_HK
dc.identifier.issue3en_HK
dc.identifier.spage100en_HK
dc.identifier.epage104en_HK
dc.identifier.isiWOS:000181634400004-
dc.publisher.placeAustraliaen_HK
dc.identifier.scopusauthoridTing, ACW=7102858552en_HK
dc.identifier.scopusauthoridCheng, SWK=7404684779en_HK
dc.identifier.scopusauthoridHo, P=24469553100en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats